Physician profile
Shivani Gupta
NPI 1194920595
$5,877.47
in general payments reported to CMS, 2019-2025
10 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $174 · 2022: $2,401 · 2023: $2,729 · 2024: $21.68 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,450 · Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,450.00 |
| Food and Beverage | $557.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $5,064.80 | 2019-2023 | Tepezza |
| Revance Therapeutics, INC. | $200.15 | 2025 | Daxxify |
| Allergan, INC. | $185.37 | 2019-2020 | |
| Abbvie INC. | $180.19 | 2023 | |
| Genentech USA, INC. | $143.65 | 2022 | |
| Argenx US, INC. | $40.12 | 2025 | |
| Amgen INC. | $37.73 | 2024-2025 | Tepezza |
| Hologic Sales and Service, LLC | $14.27 | 2019 | |
| Lilly USA, LLC | $11.19 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivani Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.